The board of directors of Allergan plc (NYSE:AGN) declared on Friday its dividend of USD0.74 per ordinary share for the second quarter of 2019.

This cash dividend will be payable on 14 June 2019 to shareholders of record at the close of business as of 14 May 2019.

Headquartered in Dublin, Ireland, the pharmaceutical company is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

In addition, the company markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology.